Reported in PharmaPhorum a chatbot helping patients with breast cancer is to hit the key US market after attracting 10,000 users in its home market of France. The French firm Wefight developed Vik Breast, a chatbot, to help with patients’ concerns and unveiled the tech at the Consumer Electronics Show in Las Vegas recently.
Vik Breast is a virtual companion that uses artificial intelligence and is able to respond to almost any question from patients, at any time.
The app can also be used by relatives, and an English version will be revealed early next year.
Freely available on IOS and Android platforms and via Facebook Messenger, Vik Breast does not replace a doctor but instead brings everyday tips and helps to improve quality of life for patients.
Topics covered include treatment, how medication should be taken and how to deal with the side effects. Vik Breast can also send reminders for appointments and taking medication, as well as information about clinical trial recruitment.
All advice is written and checked by doctors or pharmacists and is regularly updated in line with national regulations and scientific publications.
https://pharmaphorum.com/news/breast-cancer-chatbot-to-launch-in-us/